Rankings
▼
Calendar
JAZZ FY 2021 Earnings — Jazz Pharmaceuticals plc Revenue & Financial Results | Market Cap Arena
JAZZ
Jazz Pharmaceuticals plc
$12B
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$3.1B
+30.9% YoY
Gross Profit
$2.7B
85.8% margin
Operating Income
$170M
5.5% margin
Net Income
-$329M
-10.6% margin
EPS (Diluted)
$-5.51
Cash Flow
Operating Cash Flow
$779M
Free Cash Flow
$733M
Stock-Based Comp.
$189M
Balance Sheet
Total Assets
$12.3B
Total Liabilities
$8.3B
Stockholders' Equity
$4.0B
Cash & Equivalents
$591M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$3.1B
$2.4B
+30.9%
Gross Profit
$2.7B
$2.2B
+19.8%
Operating Income
$170M
$378M
-55.0%
Net Income
-$329M
$239M
-237.9%
← Q4 2020
All Quarters
Q1 2021 →